HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.

AbstractBACKGROUND:
Pancreatic cancer is characterized by extensive metastasis. Epithelial-mesenchymal transition (EMT) plasticity plays a critical role in tumor progression and metastasis by maintaining the transition between EMT and mesenchymal-epithelial transition states. Our aim is to understand the molecular events regulating metastasis and EMT plasticity in pancreatic cancer.
METHODS:
The interactions between a cancer-promoting zinc transporter ZIP4, a zinc-dependent EMT transcriptional factor ZEB1, a coactivator YAP1, and integrin α3 (ITGA3) were examined in human pancreatic cancer cells, clinical specimens, spontaneous mouse models (KPC and KPCZ) and orthotopic xenografts, and 3-dimensional spheroid and organoid models. Correlations between ZIP4, miR-373, and its downstream targets were assessed by RNA in situ hybridization and immunohistochemical staining. The transcriptional regulation of ZEB1, YAP1, and ITGA3 by ZIP4 was determined by chromatin immunoprecipitation, co-immunoprecipitation, and luciferase reporter assays.
RESULTS:
The Hippo pathway effector YAP1 is a potent transcriptional coactivator and forms a complex with ZEB1 to activate ITGA3 transcription through the YAP1/transcriptional enhanced associate domain (TEAD) binding sites in human pancreatic cancer cells and KPC-derived mouse cells. ZIP4 upregulated YAP1 expression via activation of miR-373 and inhibition of the YAP1 repressor large tumor suppressor 2 kinase (LATS2). Furthermore, upregulation of ZIP4 promoted EMT plasticity, cell adhesion, spheroid formation, and organogenesis both in human pancreatic cancer cells, 3-dimensional spheroid model, xenograft model, and spontaneous mouse models (KPC and KPCZ) through ZEB1/YAP1-ITGA3 signaling axis.
CONCLUSION:
We demonstrated that ZIP4 activates ZEB1 and YAP1 through distinct mechanisms. The ZIP4-miR-373-LATS2-ZEB1/YAP1-ITGA3 signaling axis has a significant impact on pancreatic cancer metastasis and EMT plasticity.
AuthorsMingyang Liu, Yuqing Zhang, Jingxuan Yang, Hanxiang Zhan, Zhijun Zhou, Yuanyuan Jiang, Xiuhui Shi, Xiao Fan, Junxia Zhang, Wenyi Luo, Kar-Ming A Fung, Chao Xu, Michael S Bronze, Courtney W Houchen, Min Li
JournalGastroenterology (Gastroenterology) Vol. 160 Issue 5 Pg. 1771-1783.e1 (04 2021) ISSN: 1528-0012 [Electronic] United States
PMID33421513 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Cation Transport Proteins
  • ITGA3 protein, human
  • Integrin alpha3
  • Itga3 protein, mouse
  • MIRN373 microRNA, human
  • MIRN373 microRNA, mouse
  • MicroRNAs
  • SLC39A4 protein, human
  • Slc39a4 protein, mouse
  • Transcription Factors
  • YAP-Signaling Proteins
  • YAP1 protein, human
  • Yap1 protein, mouse
  • ZEB1 protein, human
  • ZEB1 protein, mouse
  • Zinc Finger E-box-Binding Homeobox 1
  • Zinc
Topics
  • Adaptor Proteins, Signal Transducing (genetics, metabolism)
  • Animals
  • Cation Transport Proteins (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Movement
  • Cell Plasticity
  • Epithelial-Mesenchymal Transition
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Integrin alpha3 (genetics, metabolism)
  • Mice
  • MicroRNAs (genetics, metabolism)
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Pancreatic Neoplasms (genetics, metabolism, pathology)
  • Signal Transduction
  • Spheroids, Cellular
  • Transcription Factors (genetics, metabolism)
  • YAP-Signaling Proteins
  • Zinc (metabolism)
  • Zinc Finger E-box-Binding Homeobox 1 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: